Cablivi

Genzyme Corporation🇺🇸 United States

FDA Page

Effective Date: Apr 24, 2026
Approval ID: 2348f06e-8004-4040-832e-e9e86a39f905
Products: 1 registered
Version: 12

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CABLIVI safely and effectively. See full prescribing information for CABLIVI. CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use Initial U.S. Approval: 2019

Quick Stats

Total Products1

Labelers2

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.